Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cabozantinib
cabozantinib
Where Is Exelixis In The Cancer Therapeutics Market?
Seeking Alpha
Mon, 04/1/13 - 11:01 am
Exelixis
cabozantinib
Cometriq
cancer
Exelixis' Crowning Achievement
Motley Fool
Sat, 12/1/12 - 09:26 am
Exelixis
cabozantinib
Cometriq
thyroid cancer
medullary thyroid cancer
Exelixis Traders Brace For Upcoming FDA Decision
Seeking Alpha
Tue, 11/27/12 - 11:10 am
FDA
Exelixis
medullary thyroid cancer
cabozantinib
2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool
Mon, 11/26/12 - 10:56 am
Theravance
Vibativ
cabozantinib
Exelis
medullary thyroid cancer
pneumonia
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Mon, 11/26/12 - 10:55 am
cabozantinib
FDA
Exelixis
medullary thyroid cancer
Exelixis Stock Treads Water Ahead Of FDA Decision
Seeking Alpha
Sat, 10/27/12 - 11:30 am
cabozantinib
medullary thyroid cancer
thyroid cancer
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Arqule
tivantinib
Exelixis
cabozantinib
non-small cell lung cancer
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Yahoo/BusinessWire
Sun, 09/30/12 - 10:31 am
cabozantinib
Exelixis
solid tumors
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thu, 08/30/12 - 09:46 am
Exelixis
cabozantinib
medullary thyroid cancer
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Yahoo
Mon, 07/30/12 - 11:00 am
FDA
cabozantinib
medullary thyroid cancer
Exelixis
Can Exelixis Continue Making Big Moves?
Seeking Alpha
Thu, 07/12/12 - 10:56 am
Exelixis
cabozantinib
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tue, 06/5/12 - 09:34 am
cabozantinib
Exelixis
BMS-936558
MDX-1106
cancer
anti-PD-1 immunotherapy
Bristol-Myers Squibb
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Sun, 06/3/12 - 11:09 am
cabozantinib
renal cell carcinoma
Exelixis
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Buy, Sell, or Hold: Exelixis
Motley Fool
Sat, 03/24/12 - 11:38 am
cabozantinib
prostate cancer
Exelixis
Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Mon, 03/5/12 - 11:12 am
Exelixis
cabozantinib
abiraterone
prostate cancer
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma
Yahoo/BusinessWire
Sat, 01/21/12 - 12:41 pm
Exelixis
cabozantinib
hepatocellular carcinoma
Exelixis 2011: Not What the Doctor Ordered
Motley Fool
Wed, 12/28/11 - 10:05 am
Exelixis
cabozantinib
medullary thyroid cancer
Time decay is key to Exelixis strategy
Yahoo/optionMONSTER
Tue, 11/22/11 - 11:58 am
Exelixis
cabozantinib
prostate cancer
Pages
« first
‹ previous
1
2
3
next ›
last »